Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
September 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
September 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Helen Blumen, MD, MBA
Authored Items
The Clinical and Economic Burden of Hyperkalemia on Medicare and Commercial Payers
Kathryn Fitch, RN, MEd
,
Quang T. Nguyen, DO, FACE, FTOS
,
J. Michael Woolley, PhD
,
Tyler Engel, ASA, MAAA
,
Helen Blumen, MD, MBA
June 2017 Vol 10, No 4
in
Business
,
Original Research
Comparison of Treatment Costs for Breast Cancer, by Tumor Stage and Type of Service
Michael Kleinrock
,
Helen Blumen, MD, MBA
,
Kathryn Fitch, RN, MEd
,
Vincent Polkus, MSEM, MBA
February 2016 Vol 9, No 1
in
Original Research
Longitudinal Commercial Claims–Based Cost Analysis of Diabetic Retinopathy Screening Patterns
Kathryn Fitch, RN, MEd
,
Thomas Weisman, MD,MBA
,
Sharon Glave Frazee, PhD, MPH
,
Tyler Engel, ASA, MAAA
,
Adam Turpcu, PhD
,
Helen Blumen, MD, MBA
,
Yamina Rajput, MS
,
Purav Dave, MS, MBA
September 2015 Vol 8, No 6
in
Clinical
National Burden of Preventable Adverse Drug Events Associated with Inpatient Injectable Medications: Healthcare and Medical Professional Liability Costs
Betsy J Lahue, MPH
,
Jaan Sidorov, MD, MHSA
,
Bruce S. Pyenson, FSA, MAAA
,
Kosuke Iwasaki, FIAJ, MAAA
,
Helen Blumen, MD, MBA
,
Susan Forray, FCAS, MAAA
,
Jeffrey M. Rothschild, MD, MPH
November/December 2012 Vol 5, No 7
in
Clinical
Last modified: April 23, 2019